MidMichigan Medical Center

Midland, Michigan 48670

0 studies enrolling now · 8 studies all time

What they study most

Acute Kidney Injury (AKI), Atrial Fibrillation, Cardiovascular Disease, Congestive Heart Failure, Coronary Artery Disease, Covid19, High Cardiovascular Risk, Left Ventricular (LV) Systolic Dysfunction, Locally Advanced Metastatic NSCLC, Locally Advanced Unresectable NSCLC, Myocardial Infarction, Non Small-cell Lung Cancer

Studies at this site

• Expanded Access of Sotorasib — NO_LONGER_AVAILABLE
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System — Stopped early
• TAXUS Libertē Post Approval Study — Completed